• Biohaven Pharmaceuticals

Advancing Science Through Clinical Trials

Clinical trials help us to understand more about pediatric migraine and develop innovative treatments. Listen to 12-year old Eva and her mom talk about their experience participating in a clinical trial and why they feel it's important to help advance science.

Biohaven Pharmaceuticals is studying an investigational drug, to potentially treat migraines in the pediatric population. If you or your child, between 6 and 17 years of age, suffer from migraine for at least 6 months you may qualify. Learn more about our pediatric migraine study.

23 views0 comments

Recent Posts

See All